Marshall Wace’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.5K | Buy |
+24,867
| New | +$89.5K | ﹤0.01% | 2410 |
|
|
2025
Q1 | – | Sell |
-77,581
| Closed | -$260K | – | 2473 |
|
|
2024
Q4 | $260K | Buy |
+77,581
| New | +$260K | ﹤0.01% | 2125 |
|
|
2024
Q3 | – | Sell |
-182,326
| Closed | -$603K | – | 2292 |
|
|
2024
Q2 | $603K | Buy |
+182,326
| New | +$603K | ﹤0.01% | 1721 |
|
|
2023
Q3 | – | Sell |
-33,674
| Closed | -$126K | – | 1840 |
|
|
2023
Q2 | $126K | Buy |
+33,674
| New | +$126K | ﹤0.01% | 1861 |
|
|
2022
Q1 | – | Sell |
-4,949
| Closed | -$44K | – | 2615 |
|
|
2021
Q4 | $44K | Sell |
4,949
-334,604
| -99% | -$2.97M | ﹤0.01% | 2877 |
|
|
2021
Q3 | $11.9M | Buy |
339,553
+240,847
| +244% | +$8.44M | 0.05% | 409 |
|
|
2021
Q2 | $2.12M | Buy |
+98,706
| New | +$2.12M | 0.01% | 1109 |
|